About Casey Lynch
Casey Lynch is a chief executive officer and director at Lighthouse Pharmaceuticals.
Casey Lynch reports to the SEC as a director or officer of 2 public companies: Longboard Pharmaceuticals (LBPH) and Quince Therapeutics (QNCX).
Casey Lynch appears on fund filings for ACP Investment.
Casey Lynch first appears on SEC filings in 2013.
Experience
This experience comes from Casey Lynch's profile and from SEC filings. For roles taken from filings, the years are when the filings name Casey Lynch in the role, so the role may have started earlier or lasted longer.
CA
CataCap Current
Empower Her Investment Committee
2024 – Present
UC
UCLA Current
Life Science Dean's Board
2024 – Present
ST
Sinaptica Therapeutics Current
Advisor
2023 – Present
Lighthouse Pharmaceuticals, Inc. Current
Chief Executive Officer, Director, & Co-founder (2022 – Present)
Director
2022 – Present · Novato, CA
Develops experimental medicines for people with neurodegenerative and inflammatory diseases.
SB
Sonoma Bioventures Current
Managing Partner
2022 – Present
AF
Alzheimer's Drug Discovery Foundation
Business Review Board Member
2022 – 2025
LI
Longboard Pharmaceuticals, Inc.
Director
2021 – 2024 · Public company (LBPH)
AI
QI
Quince Therapeutics, Inc.
Chief Executive Officer and director
2019 – 2022 · Public company (QNCX)
CI
Cortexyme Inc.
CEO, Co-founder & Chairman
2013 – 2022
CC
California Life Sciences Association (CLSA)
Member of the Board of Directors
2019 – 2021
NL
NeuroInsights, LLC
Managing Partner and Co-Founder
2004 – 2015
NO
Neurotechnology Industry Organization
Board Member & Co-Founder
2005 – 2014
AB
Aspira Biosystems
CEO, Co-Founder, and Chairman of the Board
1999 – 2004
US
UCSF/ Stanford
Doctoral Research, Department of Neuroscience
1996 – 1999
CR
Centaur Pharmaceuticals (acquired by Renovis)
New Opportunities
1995 – 1996
VA
VA Medical Center Los Angeles
Hippocampal Research Laboratory
1993 – 1995
Key Colleagues at Startups
The people Casey Lynch works with at each company, as listed on that company's latest Form D.
Lighthouse Pharmaceuticals, Inc. · Form D, May 7, 2026
CM
Campbell Murray
Director
SD
Stephen Dominy
Director